Central Laboratories Applications & Studies

91. Small But Growing Biotech Manages Disclosure, Maintains Compliance, And Keeps Its Promise To Patients 4/11/2019

    For this biotech, the big challenge was both a lack of expertise and resources needed to manage registration of trials and posting results. TrialScope provided a proven solution that optimizes the efficiency of disclosure activities, maximizes trial data transparency, and fosters more informed, engaged patients through open research sharing.

92. Advancing A Diabetes Multi-Registration Program 3/11/2019

    A large pharmaceutical company asked Covance to support their studies for a diabetes Phase III program specifically to register a drug to treat Type 2 Diabetes. Read how Covance utilized its rich central laboratory services database and helped the sponsor achieve first patient in (FPI) ahead of schedule for all studies in the program and beat historical industry performance across a number of key metrics.

93. Optimizing Protocol Design And Enhancing Patient Enrollment 3/8/2019

    An emerging biopharmaceutical company was designing a Phase II trial in patients who had Type 2 Diabetes, Stage 3 chronic kidney disease (CKD) and macroalbuminuria. They were uncertain about how to balance the selection of the right patients for their trial endpoints with the ability to achieve rapid subject recruitment. Read how LabCorp de-identified clinical laboratory data helped evaluate the protocol feasibility and the overall design of the study while also making an adjustment in eligibility criteria was forecast to double the eligible patient pool – without impacting study endpoints.

94. The Complex Issues With Developing A Novel Human Antibody From Scratch 12/26/2018

    Having the right specialists on their team enables Premier Research to recruit subjects relatively quickly, despite extremely complex selection criteria for this multiple myeloma clinical trial. In addition, maintaining a close and cooperative customer relationship assisted in moving the study forward.

95. Lengthy Cancer Drug Study Using Dozens Of Sites Yields Positive Results 12/26/2018

    After lengthy recruiting process and a five year long clinical trial spread across more than two dozen sites, sponsor calls study results “an unexpectedly huge step forward” in overcoming the limited efficacy of current treatments and continues partnership with CRO.

96. CRO Helps To Identify A Highly Productive Location For Siting Future Studies 12/26/2018

    Compromised data collection effectively stalled a clinical trial study of an inflammation control drug. With help from a CRO, important lessons were learned about the need for discipline and following protocol as well as the identification of Russia as a highly desirable site for clinical trials.

97. Solution For Independent Data Monitoring Committee Services 10/31/2018

    Client turns to this CRO when they needed a team experienced with the full range of IDMC activities to provide a seamless solution.

98. A Top 10 Sponsor Improves Trial Data Quality Through EDC eSource Solution 9/4/2018

    Be viewed as an industry leader while at the same time benefiting from higher quality data and a need for fewer resources with use of an innovative eSource solution.

99. New Packaging Strategy Optimizes Supplies And Prevents Break In Enrollment 7/24/2018

    Direction from a solution provider with expertise in forecasting, packaging, labeling and distribution along with services of an IRT provider solves drug shortage challenge.

100. Achieving Clinical Operations Excellence 8/30/2017

     Learn how Revvity Signals Software clinical solutions give clinical operations organizations the unprecedented ability to reduce the time, cost and risk of running clinical trials while accelerating the time to market for products across the entire portfolio of clinical candidates.